Otsuka Holdings
4578.T
#691
Rank
โ‚น2.478 T
Marketcap
โ‚น4,614
Share price
1.17%
Change (1 day)
33.48%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2024 (TTM): โ‚น81.50 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚น14.47 Billion. In 2023 the company made an earning of โ‚น90.04 Billion a decrease over its 2022 earnings that were of โ‚น113.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น81.50 B-9.49%
2023 โ‚น90.04 B-20.82%
2022 โ‚น113.73 B-13.04%
2021 โ‚น130.79 B-19.69%
2020 โ‚น162.86 B13.78%
2019 โ‚น143.14 B52.13%
2018 โ‚น94.09 B11.32%
2017 โ‚น84.53 B-36.26%
2016 โ‚น132.62 B31.64%
2015 โ‚น100.74 B
2013 โ‚น209.63 B33.73%
2012 โ‚น156.75 B-4.78%
2011 โ‚น164.62 B46.23%
2010 โ‚น112.57 B